Home > Publications > Medical Specialty > Psychiatry > Schizophrenia > Schizophrenia Research Review Issue 46
Schizophrenia Research Review Issue 46

Schizophrenia Research Review Issue 46

In this issue:

Challenge: virtual reality-assisted therapy for verbal auditory hallucinations
Real-world clozapine augmentation with antidepressants
OPTiMiSE: extrapyramidal symptoms in first-episode schizophrenia
Paternal age, de novo mutations & schizophrenia onset
A botulinum neurotoxin clinic for clozapine-induced sialorrhea
Metacognitive training for psychosis
Real-world antipsychotic discontinuation & switching
Retinal age gap, hypertension & diabetes in schizophrenia
Brief vs. ultra-brief ECT in schizophrenia
PURPOSE: omega-3 fatty acids in youth at ultra-high risk of psychosis

You need to be logged in to access this content.

dan siskind

Expert contributor

Professor Dan Siskind

Professor Siskind trained as a psychiatrist in Australia and the United States. He works clinically as a psychiatrist in Brisbane, Australia with people with treatment-refractory schizophrenia. His research interests include treatment-refractory schizophrenia, clozapine and the physical health comorbidities associated with schizophrenia. He has over 300 publications and AU$60million in competitive research grants, with over AU$7 […]

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.